Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52. (Q41253815)

28 September 2017

Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52. (English)

1 reference

28 September 2017

F A Verreck

1

1 reference

28 September 2017

A van de Poel

2

1 reference

28 September 2017

J W Drijfhout

3

1 reference

28 September 2017

R Amons

4

1 reference

28 September 2017

J E Coligan

5

1 reference

28 September 2017

F Konig

6

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 January 1996

1 reference

28 September 2017

1 reference

28 September 2017

43

1 reference

28 September 2017

6

1 reference

28 September 2017

392-397

1 reference

Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers

28 September 2017

1 reference

12 December 2020

HLA-Dw14 and HLA-DR3 haplotypes share a functional determinant recognized by a human alloreactive T-cell clone

1 reference

12 December 2020

DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin

1 reference

12 December 2020

A mouse monoclonal antibody detecting a DR-related MT2-like specificity: Serology and biochemistry

1 reference

12 December 2020

Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands

1 reference

12 December 2020

Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides

1 reference

12 December 2020

Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recognition

1 reference

12 December 2020

The impact of naturally occurring DR3 microvariants, DRw17 and DRw18, on T-cell allorecognition

1 reference

12 December 2020

MHC ligands and peptide motifs: first listing

1 reference

12 December 2020

Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak crossreacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differenti

1 reference

12 December 2020

Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif

1 reference

12 December 2020

DR-restricted T-cell reactivities associated with the Dw19 specificity can be directed against the products of either locus DRB3 (DRw52c) or locus DRB1.

1 reference

12 December 2020

Critical role for the Val/Gly86 HLA-DR beta dimorphism in autoantigen presentation to human T cells

1 reference

12 December 2020

Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming

1 reference

12 December 2020

Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis

1 reference

12 December 2020

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

1 reference

12 December 2020

HLA-DR beta chain residue 86 controls DR alpha beta dimer stability

1 reference

12 December 2020

The generation of SDS-stable HLA DR dimers is independent of efficient peptide binding

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002510050081

1 reference

28 September 2017

1 reference